Artificial Intelligence Generator Software Articles & Analysis
16 news found
Transpara, the world's leading artificial intelligence (AI) breast care software, has now reached a major new milestone, helping radiologists read over three million mammograms. Across the US, Transpara is providing hundreds of radiologists with a 'second pair' of eyes helping detect cancers earlier and reduce recall rates. Among the radiologists using this revolutionary AI breast care system, ...
For VisionQuest’s vice president and principal investigator Vinayak Joshi (PhD), the journey from idea to commercial product has led him halfway around the world. Dr. Joshi recently traveled to Malawi, Kenya, Nigeria, and Ghana as part of his efforts to commercialize ASPIRE, his device for the detection and diagnosis of malarial retinopathy. While in Africa, he met with leaders in ...
Virusight Diagnostic, a world leader in combining artificial intelligence software and spectral technology today announced the results of a major clinical study that found its ultra-rapid, point of care Pathogens Diagnostic solution consistently delivers 96.3% accuracy when compared to the gold standard RT-PCR. ...
Proprietary technologies are being developed to enrich pathogenic DNA / RNA for analysis through harnessing the power of Next-Generation Sequencing platforms and proprietary artificial intelligence-based software analytics with the goal to rapidly identify and detect any foreign pathogens (virus, bacteria, fungus, parasites) ...
Subtle Medical was awarded an NIH SBIR grant to develop an innovative artificial intelligence (AI)-powered software, SubtleIR™, which uses deep learning (DL) to reduce radiation dosage needed during fluoroscopy exams. The development of the new software is aligned with the company’s mission to accelerate access to faster, safer, and smarter medical imaging. Subtle continues to ...
Volta Medical, a pioneering health tech company developing artificial intelligence (AI)-based software solutions to treat cardiac arrythmias, today announced the introduction of its leading-edge product, VX1, at three leading U.S. hospitals. ...
QView Medical, a breast cancer detection pioneer and maker of the FDA-approved artificial intelligence (AI) software system for breast cancer screening, and GE Healthcare today announced that QView's QVCAD software can be launched on GE Healthcare's Invenia™ ABUS 2.0 (Automated Breast Ultrasound), which has an open platform ...
BOSTON, MA, November 22, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an artificial intelligence (AI)-powered neuroimaging software platform for central nervous system (CNS) disorders, will unveil its new brand and latest AI developments as a key exhibitor in the AI Showcase at the 107th Radiology Society of North America (RSNA) Annual Meeting, from ...
ByQynapse
Axial3D is delighted to be working in partnership with NeuroNav to improve the neurosurgical navigation workflow using artificial intelligence (AI). Neurosurgery procedures are extremely complex requiring high precision to avoid damage to vital structures of the brain. ...
ByAxial3D
Immunai has taken some important steps toward its quest to map the entire immune system by completing its second acquisition this year and bolstering its management and board with new executive and entrepreneurial expertise. Immunai has acquired the Swiss-based biocuration and data integration company Nebion for an undisclosed sum. The deal should extend Immunai’s target discovery and drug ...
ByImmunai
Computed tomography angiography (CTA) has been increasingly used in the diagnosis of vascular disease and its a modality that offers many potential clinical benefits. The question is, how to actualize that benefit and get the most our of the modality. Elucid has developed an artificial intelligence software that might just answer that question. How AI Can Improve CTA Analysis ...
ByElucid
Volta Medical, a pioneering French-based HealthTech startup is pleased to announce that it has obtained FDA clearance for its revolutionary VX1 AI (artificial intelligence) software. This is the first FDA clearance for an AI based tool in interventional cardiac electrophysiology. ...
Side effects of drugs can have fatal consequences. It is therefore important to detect these side effects at an early stage. This is exactly what a new method developed by the Dresden-based start-up PharmAI GmbH and its partner, 2bind GmbH from Regensburg, is making possible. The two companies’ method combines artificial intelligence with highly efficient biophysical testing. The challenge ...
ORLANDO, FL – January 17, 2020 – AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company that is in the process of building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence, machine learning and proprietary software; is attending the 38th J.P. Morgan ...
A New York City based large volume private practice radiology group conducted a quality assurance review that included an 18 month software evaluation in the breast center comprised of nine (9) specialist radiologists using an FDA cleared artificial intelligence software by Koios Medical, Inc as a second opinion for analyzing and ...
ORLANDO, Fla., Aug. 28, 2019 (GLOBE NEWSWIRE) — AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), an emerging growth company that is in the process of building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence, machine learning and proprietary software; announced today that its regulatory and management teams ...